Durham, N.C. – January 24, 2018 – Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the first patient has been enrolled in the post approval study to evaluate the Tryton Side Branch Stent System™ for the treatment of coronary artery disease. The first case was performed by R. Lee Jobe, M.D., …

Durham, N.C. – Jan. 3, 2018 – Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the company has appointed Carl J. St. Bernard as president and chief executive officer. St. Bernard has a long track record growing new and established businesses in pharmaceuticals, consumer health products, medical devices and diagnostic markets. …

DUBLIN, Ohio, September 19, 2017 — Cardinal Health and Tryton Medical Inc. today announced that the Tryton coronary Side Branch Stent was recognized by Premier Inc., a leading healthcare improvement company, with the prestigious Technology Breakthrough Award. Premier’s Technology Breakthrough Award is granted to cutting-­edge products that significantly advance healthcare in terms of safety, clinical outcomes and/or operational efficiency. The …